You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

arn-509

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +2 more
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • ARN-509
  • +2 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Prostate Cancer Trial in United States (ARN-509, Abiraterone, Leuprolide)

Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +3 more
  • Baltimore, Maryland
  • +10 more
Feb 8, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +2 more
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • ARN-509
  • LHRH Agonist
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Healthy Trial in Groningen (ARN-509)

Completed
  • Healthy
  • ARN-509
  • Groningen, Netherlands
    PRA - Clinical Research Unit, University Medical Centre Groninge
Sep 12, 2013